Perspective Therapeutics, Inc. — Director's Dealing 2020

Dec 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Isoray, Inc. (ISR)
CIK: 0000728387
Period of Report: 2020-11-30

Reporting Person: Woods Lori A (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-30	Common Stock	P	68000	$0.3755	Acquired	610500	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	48076	Direct